Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Lormetazepam
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lormetazepam 1mg tablets
0401010P0AAACAC
|
Lormetazepam | Lormetazepam | Central Nervous System | 2,665 |
|
Lormetazepam 500microgram tablets
0401010P0AAABAB
|
Lormetazepam | Lormetazepam | Central Nervous System | 1,037 |
|
Lormetazepam 125micrograms/5ml oral suspension
0401010P0AAAHAH
|
Lormetazepam | Lormetazepam | Central Nervous System | No data available |
|
Lormetazepam 1mg/5ml oral suspension
0401010P0AAAGAG
|
Lormetazepam | Lormetazepam | Central Nervous System | No data available |
|
Lormetazepam 2mg/5ml oral suspension
0401010P0AAAEAE
|
Lormetazepam | Lormetazepam | Central Nervous System | No data available |
|
Lormetazepam 500micrograms/5ml oral suspension
0401010P0AAAFAF
|
Lormetazepam | Lormetazepam | Central Nervous System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.